Predominance of small dense low-density lipoproteins and abnormal glucose regulation in patients with acute coronary syndrome

Circulation Journal

Volumn 70, Issue 4, 2006, Pages 393-401

  Ban, Yoshihisa ^a   Koba, Shinji ^a   Tsunoda, Fumiyoshi ^a   Yokota, Yuuya ^a   Ezumi, Hitoshi ^a   Kondo, Takeshi ^a   Suzuki, Hiroshi ^a   Katagiri, Takashi ^a  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute coronary syndrome; Diabetes mellitus; Impaired glucose tolerance; Oral glucose tolerance test; Small dense LDL

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; ATHEROGENESIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GEL ELECTROPHORESIS; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HUMAN; MALE; ORAL GLUCOSE TOLERANCE TEST; PREVALENCE; PROTEIN METABOLISM;

AGED; AGED, 80 AND OVER; ANGINA, UNSTABLE; BLOOD GLUCOSE; DIABETES MELLITUS; DYSLIPIDEMIAS; FEMALE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; INSULIN RESISTANCE; JAPAN; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RETROSPECTIVE STUDIES; SYNDROME;

EID: 33645343038     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.70.393     Document Type: Article

References (45)

1. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993; 16: 434-444.
2. Miettinen H, Lehto S, Salomaa V, Mahonen M, Niemela M, Haffner SM, et al. Impact of diabetes on mortality after the first myocardial infarction. Diabetes Care 1998; 21: 69-75.
3. Malmberg K, Yusuf S, Gerstein HC, Brown J, Zhao F, Hunt D, et al. Impact of diabetes on long-term prognosis in patients with unstable angina and non-q-wave myocardial infarction: Results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry. Circulation 2000; 102: 1014-1019.
4. Grundy SM, Howard B, Smith Jr S, Eckel R, Redberg R, Bonow RO. Prevention Conference VI: Diabetes and cardiovascular disease - Executive summary Conference proceedings for healthcare professionals from a special writing group of the American Heart Association. Circulation 2002; 105: 2231-2239.
5. Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK. Cardiovascular risk factors in confirmed prediabetic individuals. JAMA 1990; 263: 2893-2898.
6. Stratton JM, Adler AI, Neil HAW, Matthews DR, Manley SE, Cull CA, et al, on behalf of the UK Prospective Diabetes Study Group. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study. BMJ 2000; 321: 405-412.
7. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H. Coronary-heartdisease risk and impaired glucose tolerance: The Whitehall study. Lancet 1980; 1: 1371-1376.
8. The DECODE Study Group. Glucose tolerance and cardiovascular mortality. Arch Intern Med 2001; 161: 397-404.
9. Ceriello A. Impaired glucose tolerance and cardiovascular disease: The possible role of post-prandial hyperglycemia. Am Heart J 2004; 147: 803-807.
10. Qiao Q, Eriksson J, Jousilahti P, Tuomilehto J. Predictive properties of impaired glucose tolerance for cardiovascular risk are not explained by the development of overt diabetes during follow-up. Diabetes Care 2003; 26: 2910-2914.
11. Norhammar A, Tenerz Å, Nilsson G, Hamsten A, Efendic S, Ryden L, et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: A prospective study. Lancet 2002; 359: 2140-2144.
12. Tenerz Å, Nilsson G, Norhammar A, Ryden L, Silveira A, Malmberg K, et al. Diabetes, insulin resistance, and the metabolic syndrome in patients with acute myocardial infarction without previously known diabetes. Diabetes Care 2003; 26: 2770-2776.
13. Bartnik M, Ryden L, Ferrari R, Malmberg K, Pyörälä K, Simoons M, et al, on behalf of the Euro Heart Survey Investigators. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe: The Euro Heart Survey on diabetes and the heart. Eur Heart J 2004; 25: 1880-1890.
14. Griffin BA. Lipoprotein atherogenicity: An overview of current mechanisms. Proc Nutr Soc 1999; 58: 163-169.
15. Berneis KK, Krauss RM. Metabolic origins and clinical significance of LDL heterogeneity. J Lipid Res 2002; 43: 1363-1379.
16. Austin MA, King MC, Vranizan KM, Krauss RM. Atherogenic lipoprotein phenotype: A proposed genetic marker for coronary heart disease risk. Circulation 1990; 82: 495-506.
17. Lamarche B, Lemieux I, Després JP. The small dense LDL phenotype and the risk of coronary heart disease: Epidemiology, pathophysiology and therapeutic aspects. Diabetes Metab 1999; 25: 199-211.
18. Gardner CD, Fortmann SP, Krauss RM. Association of small dense low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA 1996; 276: 875-881.
19. Koba S, Hirano T. Small dense low-density lipoprotein in Japanese men with coronary artery disease. Ann Intern Med 2000; 132: 762.
20. Koba S, Hirano T, Yoshino G, Sakai K, Sakaue T, Adachi M, et al. Remarkably high prevalence of small dense low-density lipoprotein in Japanese men with coronary artery disease, irrespective of the presence of diabetes. Atherosclerosis 2002; 160: 249-256.
21. Koba S, Hirano T, Kondo T, Shibata M, Suzuki H, Murakami M, et al. Significance of small dense low-density lipoproteins and other risk factors in patients with various types of coronary heart diseases. Am Heart J 2002; 144: 1026-1035.
22. Tsunoda F, Koba S, Hirano T, Ban Y, Iso Y, Suzuki H, et al. Association between small dense low-density lipoprotein and postprandial accumulation of triglyceride-rich remnant-like particles in normotriglyceridemic patients with myocardial infarction. Circ J 2004; 68: 1165-1172.
23. The Examination Committee of Criteria for 'Obesity Disease' in Japan, Japan Society for the Study of Obesity. New criteria for 'obesity disease' in Japan. Circ J 2002; 66: 987-992.
24. Saito Y. Guidelines for diagnosis and treatment of atherosclerotic cardiovascular disease 2002. J Atheroscler Thromb 2002; 9: 101-103.
25. Sakaue T, Hirano T, Yoshino G, Sakai K, Takeuchi H, Adachi M. Reaction of direct LDL-cholesterol assays with pure LDL fraction and IDL: Comparison of three homogenous methods. Clin Chim Acta 2000; 295: 97-106.
26. Nichols AV, Krauss RM, Musliner TA. Nondenaturing polyacrylamide gradient gel electrophoresis. Methods Enzymol 1986; 128: 417-433.
27. Austin MA, Hokanson JE, Brunzell JD. Characterization of low-density lipoprotein subclasses: Methodologic approaches and clinical relevance. Curr Opin Lipidol 1994; 5: 395-403.
28. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-429.
29. Selzer HS, Allen EW, Herron AL Jr, Brennan MT. Insulin secretion in response to glycemic stimulus: Relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus. J Clin Invest 1967; 46: 323-335.
30. Koba S, Tsunoda F, Hirano T, Iso Y, Suzuki H, Geshi E, et al. Postprandial changes in LDL phenotypes in patients with myocardial infarction. Eur J Clin Invest 2005; 35: 171-179.
31. Warram JH, Martin BC, Krolewski AS, Soeldner JS, Kahn CR. Slow glucose removal rate and hyperinsulinolemia precede the development of type II diabetes in the offspring of diabetic parents. Ann Intern Med 1990; 113: 909-915.
32. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. I: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 20: 1183-1197.
33. Choi KM, Lee KW, Kim SG, Kim NH, Park CG, Seo HS, et al. Inflammation, insulin resistance, and glucose intolerance in acute myocardial infarction patients without a previous diagnosis of diabetes mellitus. J Clin Endocrinol Metab 2005; 90: 175-180.
34. Hashimoto K, Ikewaki K, Yagi H, Nagasawa H, Imamoto S, Shibata T, et al. Glucose intolerance is common in Japanese patients with acute coronary syndrome who were not previously diagnosed with diabetes. Diabetes Care 2005; 28: 1182-1186.
35. Reaven GM, Chen Y-DI, Jeppesen J, Maheux P, Krauss RM. Insulin resistance and hyperinsulinemia in individuals with small, dense, low density lipoprotein particles. J Clin Invest 1993; 92: 141-146.
36. Garvey WT, Kwon S, Zheng D, Shaughnessy S, Wallace P, Hutto A, et al. Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance. Diabetes 2003; 52: 453-462.
37. Goff Jr DC, D'Agostino Jr RB, Haffner SM, Otvos JD. Insulin resistance and adiposity influence lipoprotein size and subclass concentrations: Results from the Insulin Resistance Atherosclerosis Study. Metabolism 2005; 54: 264-270.
38. Laakso M. How good a marker is insulin level for insulin resistance? Am J Epidemiol 1993; 137: 959-965.
39. Stern MP, Williams K, Haffner SM. Identification of individuals at high risk of type 2 diabetes: Do we need the oral glucose tolerance test? Ann Intern Med 2002; 136: 575-581.
40. Pyörälä M, Miettinen H, Laakso M, Pyörälä K. Hyperinsulinemia predicts coronary heart disease in healthy middle-aged men: The 22-year follow-up results of the Helsinki Policemen Study. Circulation 1998; 98: 398-404.
41. Després JP, Lamarche B, Mauriége P, Cantin B, Dagenais GR, Moorjani S, et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 1996; 334: 952-957.
42. Yanase M, Takatsu F, Tagawa T, Kato T, Arai K, Koyasu M, et al. Insulin resistance and fasting hyperinsulinemia are risk factors for new cardiovascular events in patients with prior coronary artery disease and normal glucose tolerance. Circ J 2004; 68: 47-52.
43. Fukushima M, Usami M, Ikeda M, Nakai Y, Taniguchi A, Matsuura T, et al. Insulin secretion and insulin sensitivity at different stages of glucose tolerance: A cross-sectional study of Japanese type 2 diabetes. Metabolism 2004; 53: 831-835.
44. Kanauchi M, Motomiya K, Hashimoto T. Insulin secretion and sensitivity in non-obese and obese Japanese patients with coronary heart disease. Metabolism 2002; 51: 184-188.
45. DECODA. Cardiovascular risk profile assessment in glucose-intolerance Asian individuals: An evaluation of the World Health Organization two-step strategy: The DECODA Study (Diabetes Criteria in Asia). Diabet Med 2002; 19: 549-557.